Regulation on the market of products containing, consisting of or produced from genetically modified maize DP910521 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
This resolution expresses the European Parliament's objection to the European Commission's draft decision to authorize genetically modified maize DP910521 for use in food and feed. The Parliament believes the draft decision exceeds the Commission's powers and is inconsistent with EU law aiming for a high level of protection for health and the environment. The genetically modified maize, developed by Corteva Agriscience, is engineered to produce a specific toxin for insect resistance and to tolerate the herbicide glufosinate. The herbicide glufosinate itself is classified as toxic to reproduction and its approval in the EU expired in 2018. Concerns raised include the lack of assessment for the complementary herbicide's risks, potential increased herbicide use leading to resistant weeds, and adverse impacts on biodiversity and soil health. Questions are also raised about the safety of the Bt toxin, potential interactions with herbicide residues, and effects on non-target organisms. The Parliament calls on the Commission to withdraw its draft decision and submit a new one, ensuring it aligns with EU safety standards and international obligations regarding biodiversity and sustainable development. This objection follows a pattern of Parliament resolutions against the authorization of genetically modified organisms.
Analysis
The genetically modified maize DP910521 produces the Cry1B.34 toxin and is resistant to the herbicide glufosinate.
What changes
- The European Parliament calls on the Commission to withdraw its draft implementing decision authorising the placing on the market of genetically modified maize DP910521.
- The Parliament requests the Commission to submit a new draft implementing decision to the committee.
- The Commission is called upon to ensure convergence of standards between the Union and its partners in free trade agreement negotiations to meet Union safety standards.
Expected impact
- The draft Commission implementing decision is considered not consistent with Union law, as it is not compatible with the aim of providing a high level of protection for human life, animal health, and the environment.
- The Parliament calls on the Commission not to authorise the GM maize due to increased risks to biodiversity, in line with the One Health approach.
- The European Parliament considers that the draft Commission implementing decision exceeds the implementing powers provided for in Regulation (EC) No 1829/2003.
Limitations
- The document is a European Parliament resolution and does not contain the full draft Commission implementing decision, limiting the analysis of specific legal provisions being amended or introduced.
- Detailed scientific data supporting the EFSA opinion or Member State comments are not included in this text, preventing a deeper analysis of the scientific basis for concerns.
- The document does not provide specific details on the economic impact of authorising or not authorising this specific GM maize.
Shadow Rapporteurs
Some data sources haven't been updated in over 48 hours.